ENST00000396098.5:c.9+2426T>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000396098.5(LPIN1):c.9+2426T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.529 in 151,988 control chromosomes in the GnomAD database, including 22,765 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.53 ( 22765 hom., cov: 32)
Consequence
LPIN1
ENST00000396098.5 intron
ENST00000396098.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.508
Publications
6 publications found
Genes affected
LPIN1 (HGNC:13345): (lipin 1) This gene encodes a magnesium-ion-dependent phosphatidic acid phosphohydrolase enzyme that catalyzes the penultimate step in triglyceride synthesis including the dephosphorylation of phosphatidic acid to yield diacylglycerol. Expression of this gene is required for adipocyte differentiation and it also functions as a nuclear transcriptional coactivator with some peroxisome proliferator-activated receptors to modulate expression of other genes involved in lipid metabolism. Mutations in this gene are associated with metabolic syndrome, type 2 diabetes, acute recurrent rhabdomyolysis, and autosomal recessive acute recurrent myoglobinuria (ARARM). This gene is also a candidate for several human lipodystrophy syndromes. [provided by RefSeq, Mar 2017]
LPIN1 Gene-Disease associations (from GenCC):
- myoglobinuria, acute recurrent, autosomal recessiveInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
- hereditary recurrent myoglobinuriaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.738 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LOC124907735 | XR_007086220.1 | n.1606A>G | non_coding_transcript_exon_variant | Exon 1 of 2 | ||||
| LPIN1 | NM_001261428.3 | c.139-21679T>C | intron_variant | Intron 2 of 21 | NP_001248357.1 | |||
| LPIN1 | NM_001349207.2 | c.82-21679T>C | intron_variant | Intron 1 of 20 | NP_001336136.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LPIN1 | ENST00000396098.5 | c.9+2426T>C | intron_variant | Intron 2 of 9 | 1 | ENSP00000379405.1 | ||||
| LPIN1 | ENST00000449576.6 | c.139-21679T>C | intron_variant | Intron 2 of 21 | 2 | ENSP00000397908.2 | ||||
| LPIN1 | ENST00000396097.5 | c.9+2426T>C | intron_variant | Intron 2 of 21 | 5 | ENSP00000379404.2 |
Frequencies
GnomAD3 genomes AF: 0.529 AC: 80275AN: 151870Hom.: 22740 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
80275
AN:
151870
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.529 AC: 80354AN: 151988Hom.: 22765 Cov.: 32 AF XY: 0.521 AC XY: 38691AN XY: 74308 show subpopulations
GnomAD4 genome
AF:
AC:
80354
AN:
151988
Hom.:
Cov.:
32
AF XY:
AC XY:
38691
AN XY:
74308
show subpopulations
African (AFR)
AF:
AC:
30861
AN:
41446
American (AMR)
AF:
AC:
7089
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
1565
AN:
3470
East Asian (EAS)
AF:
AC:
1218
AN:
5152
South Asian (SAS)
AF:
AC:
1877
AN:
4820
European-Finnish (FIN)
AF:
AC:
4530
AN:
10582
Middle Eastern (MID)
AF:
AC:
126
AN:
292
European-Non Finnish (NFE)
AF:
AC:
31551
AN:
67936
Other (OTH)
AF:
AC:
1041
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1797
3594
5391
7188
8985
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
678
1356
2034
2712
3390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1113
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.